drugset
drugset / Trial / NCT04090203

Boiled Peanut Oral Immunotherapy

NCT04090203 ↗

Phase 1 Completed 8 enrolled Alton Melton The Cleveland Clinic · collab
NaSingle-groupOpen-labelTreatment

Summary

Prospective Phase 1 clinical trial providing proof of concept data on boiled peanut oral immunotherapy (OIT) for the treatment of peanut allergy in children. The investigators hypothesize that the proportion of subjects successfully desensitized with boiled peanut OIT is greater than the theoretical placebo rate of 20%.

Timeline

Start
2019-11-05
Primary completion
2021-05-20
Completion
2021-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Boiled Peanut Powder Unknown 300 mg Oral

Indications

No indication recorded.